Variables | N | % | HR (95%CI) |
---|---|---|---|
The family history of breast cancer | |||
 No | 133 | 92.40% | 0.969 (0.258–3.640) |
 Yes | 11 | 7.60% | ref |
Parity | |||
 Nulliparity | 17 | 11.80% | 1.925 (0.647–5.730) |
 Multiparity | 127 | 88.20% | ref |
Chief presentation | |||
 Breast lump | 94 | 65.30% | 1.295 (0.6–2.795) |
 Skin induration or lesion | 37 | 25.70% | ref |
 Axillary mass | 4 | 2.80% | |
 Pain | 9 | 6.30% | |
Positive biopsy diagnosis | |||
 Fine needle aspiration | 82 | 56.90% | N/A |
 Biopsy | 62 | 43.10% | N/A |
Localization | |||
 Right | 68 | 47.20% | 3.839 (1.045–14.112) |
 Left | 51 | 39.60% | |
 Bilateral | 19 | 13.20% | ref |
Multifocal lumps | |||
 No | 118 | 82% | 3.839 (1.045–14.112) |
 Yes | 26 | 18% | ref |
Tumor size | |||
 Median | 5.5 cm |  |  |
  > 3 | 121 | 84% | 3.8 (1.04–14.11) |
  ≤ 3 | 23 | 16% | ref |
Lymph node involvement | |||
 positive | 108 | 75% | 2.159 (0.912–5.108) |
 negative | 36 | 25.00% | ref |
Stage | |||
 I | 5 | 3.50% | ref |
 II | 47 | 32.60% | |
 III | 69 | 47.900% | 0.610 (0.278–1.339) |
 IV | 23 | 16% | |
Distant metastasis at diagnosis | |||
 Yes | 23 | 16% | 8.627 (1.909–38.994) |
 No | 121 | 84% | ref |
Histology | |||
 Ductal | 117 | 81.30% | 1.568 (0.289–8.501) |
 Lobular | 12 | 8.30% | ref |
 Ductolobuler | 8 | 5.60% | |
 Others | 7 | 4.80% | |
mSBR grading | |||
 I | 1 | 0.70% | 0.836 (0.334–2.092) |
 II | 30 | 20.80% | |
 III | 113 | 78.50% | ref |
Angioinvasion | |||
 No | 6 | 4.20% | 0.761 (0.134–4.335) |
 Yes | 138 | 95.80% | ref |
Lymphatic invasion | |||
 No | 14 | 9.70% | 2.513 (0.668–9.447) |
 Yes | 130 | 90.30% | ref |
Hormonal receptor | |||
 Negative | 86 | 59.70% | 1.6 (0.753–3.398) |
 Positive | 57 | 39.60% | ref |
HER2 expression | |||
 Negative | 99 | 68.80% | 0.623 (0.281–1.382) |
 Positive | 44 | 30.60% | ref |
Molecular classification | |||
 Triple Negative | 55 | 38.20% | 2.209 (0.945–5.162) |
 Luminal | 62 | 43.10% | ref |
 HER2 | 26 | 18.10% |